Literature DB >> 26349495

The Introduction of Inversion of Polarity Sites in DNA G-Quadruplex Structures: Effects and Perspectives.

Antonella Virgilio, Veronica Esposito, Rosanna Filosa, Luciano Mayol, Aldo Galeone1.   

Abstract

The natural sequences of nucleic acids generally consist of nucleotides linked together by canonical 3'-5' phosphodiester bonds. An inversion of polarity site (IPS) can be defined as the point of the sequence in which a 3'-3' or a 5'-5' phosphodiester bond occurs. By extending this definition, an IPS can be described as that part of the sequence in which two 3'- or two 5'-hydroxyl groups are connected by a linker, variable in size or in chemical nature. In G-quadruplex structures an IPS can be introduced in three different positions: inside a non G-tract, inside a G-tract and just between a non Gtract and a G-tract. Investigations have been reported concerning all the three types of modification. This review describes the effects of the presence of one or more IPSs in G-quadruplex structures, particularly regarding their topological and structural characteristics, glycosidic bond preference, and thermal stability, with special attention to biologically active Gquadruplex forming aptamers. The perspectives and potential developments of this research area are also discussed.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26349495     DOI: 10.2174/1389557515666150909143215

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  2 in total

Review 1.  In What Ways Do Synthetic Nucleotides and Natural Base Lesions Alter the Structural Stability of G-Quadruplex Nucleic Acids?

Authors:  Janos Sagi
Journal:  J Nucleic Acids       Date:  2017-10-18

2.  Investigation and improvement of catalytic activity of G-quadruplex/hemin DNAzymes using designed terminal G-tetrads with deoxyadenosine caps.

Authors:  Yanwei Cao; Pi Ding; Luyan Yang; Wenjing Li; Yu Luo; Jine Wang; Renjun Pei
Journal:  Chem Sci       Date:  2020-06-17       Impact factor: 9.825

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.